Skip to Content

Join the 'Obiltoxaximab' group to help and get support from people like you.

Obiltoxaximab News

Inhalation Anthrax Treatment Anthim Approved

Posted 22 Mar 2016 by

MONDAY, March 21, 2016 – Anthim (obiltoxaximab) has been approved by the U.S. Food and Drug Administration to treat inhalational anthrax, a rare disease stemming from infected animal products. Bacillus anthracis spores also pose a deadly bioterrorism threat if released intentionally. Anthrax toxins can cause severe tissue damage and death, the FDA said Monday in a news release. Anthim, combined ...

FDA Approves Anthim (obiltoxaximab) for Inhalation Anthrax

Posted 22 Mar 2016 by

March 21, 2016 – On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate. Inhalational anthrax is a rare disease that can occur after exposure to ...

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups


Obiltoxaximab Patient Information at